News Daily News Front-of-Package Nutrition Info Backed by ACC to Improve CV Health Todd Neale December 10, 2025
News Daily News FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF Todd Neale December 05, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News TCT 2025 SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI Caitlin E. Cox November 06, 2025
News Conference News TCT 2025 What Makes MedTech Great—or Not—and Envisioning Its Future Caitlin E. Cox November 04, 2025
News Conference News TCT 2025 AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations Todd Neale October 31, 2025
News Daily News CMS Greenlights Reimbursement for Renal Denervation Systems L.A. McKeown October 29, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Conference News TCT 2025 More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain Yael L. Maxwell October 26, 2025
News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Conference News TCT 2025 Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE Caitlin E. Cox October 26, 2025
News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Conference News EACTS 2025 SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data Yael L. Maxwell October 10, 2025
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025